Table of Content

Executive Summary
1 Market Overview
1.1 Role of Biomarkers in Cell Analysis
1.2 Recent Advancements in Cell Analysis
1.3 Trends for Latin America Cell Analysis Market
1.4 Cell Analysis Market: Future Potential
1.5 Latin America Cell Analysis Market Scenario

2 Market Dynamics
2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Growing inclination towards single cell technology
2.2.2 Increasing focus on cell-based research across countries of Latin America
2.2.3 Increasing number of contract research organizations (CROs)
2.2.4 Rising awareness about regenerative medicine among individuals
2.2.5 Advancement in cell imaging and analysis technologies eased drug discovery process
2.3 Market Restraints
2.3.1 Stringent regulatory framework on cell analysis systems and assays
2.3.2 High costs associated with the cell analysis instruments
2.4 Market Opportunities
2.4.1 Offering of high-content screening services by contract research organizations (CROs)
2.4.2 Automation of cancer cell analysis techniques

3 Competitive Insights
3.1 Market Share Analysis
3.2 Industry Attractiveness
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyer
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products
3.2.5 Intensity of Competitive Rivalry

4 Latin America Cell Analysis Market (by Product Type)
4.1 Instruments
4.1.1 Cell Imaging Systems and Microscopes
4.1.2 Flow Cytometer
4.1.3 Quantitative PCR (qPCR) Instruments
4.1.4 Cell Counters
4.1.5 Cell Screening and High-Content Screening Systems (HCS)
4.1.6 Other Instruments
4.2 Consumables
4.2.1 Assay Kits
4.2.2 Reagents
4.2.3 Other Consumables

5 Latin America Cell Analysis Market (by End User)
5.1 Hospitals
5.2 Pharmaceutical and Biotechnology Companies
5.3 Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
5.4 Academic and Research Institutes
5.5 Other End User

6 Latin America Cell Analysis Market (by Country)
6.1 Brazil
6.2 Mexico
6.3 Argentina
6.4 Chile
6.5 Colombia
6.6 Rest-of-Latin America (RoLA)

7 Company Profiles
7.1 Overview
7.2 Becton, Dickinson and Company
7.2.1 Company Overview
7.2.2 Role of Becton, Dickinson and Company in the LATAM Cell Analysis Market
7.2.3 Overall Financials
7.2.4 Key Insights about Financial Health of the Company
7.2.5 SWOT Analysis
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Company Overview
7.3.2 Role of Bio-Rad Laboratories, Inc. in LATAM Cell Analysis Market
7.3.3 Overall Financials
7.3.4 Key Insights about Financial Health of the Company
7.3.5 SWOT Analysis
7.4 Danaher Corporation
7.4.1 Company Overview
7.4.2 Role of Danaher Corporation in LATAM Cell Analysis Market
7.4.3 Overall Financials
7.4.4 Key Insights about Financial Health of the Company
7.4.5 SWOT Analysis
7.5 F.Hoffmann-La Roche AG
7.5.1 Company Overview
7.5.2 Role of F. Hoffmann-La Roche AG in the LATAM Cell Analysis Market
7.5.3 Overall Financials
7.5.4 Key Insights about Financial Health of the Company
7.5.5 SWOT Analysis
7.6 GE Corporation
7.6.1 Company Overview
7.6.2 Role of GE Corporation in the LATAM Cell Analysis Market
7.6.3 Overall Financials
7.6.4 Key Insights about Financial Health of the Company
7.6.5 SWOT Analysis
7.7 Merck & Co., Inc.
7.7.1 Company Overview
7.7.2 Role of Merck & Co., Inc. in the LATAM Cell Analysis Market
7.7.3 Overall Financials
7.7.4 Key Insights about Financial Health of the Company
7.7.5 SWOT Analysis
7.8 Olympus Corporation
7.8.1 Company Overview
7.8.2 Role of Olympus Corporation in LATAM Cell Analysis Market
7.8.3 Overall Financials
7.8.4 Key Insights about Financial Health of the Company
7.8.5 SWOT Analysis
7.9 Perkin Elmer, Inc.
7.9.1 Company Overview
7.9.2 Role of PerkinElmer, Inc. in the LATAM Cell Analysis Market
7.9.3 Overall Financials
7.9.4 Key Insights about Financial Health of the Company
7.9.5 SWOT Analysis
7.10 QIAGEN N.V.
7.10.1 Company Overview
7.10.2 Role of Qiagen N.V. in the Cell Analysis Market
7.10.3 Overall Financials
7.10.4 Key Insights on the Financial Health of the Company
7.10.5 SWOT Analysis
7.11 Sony Biotechnology Inc.
7.11.1 Company Overview
7.11.2 Role of Sony Biotechnology Inc. in the LATAM Cell Analysis Market
7.12 Thermo Fisher Scientific, Inc.
7.12.1 Company Overview
7.12.2 Role of Thermo Fisher Scientific Inc. in LATAM Cell Analysis Market
7.12.3 Overall Financials
7.12.4 Key Insights on the Financial Health of the Company
7.12.5 SWOT Analysis

8 Research Scope and Methodology
8.1 Report Scope



List of Tables



Table 2.1: Impact Analysis

List of Figures



Figure 1: Cell Analysis Process
Figure 2: Latin America Cell Analysis Market Drivers and Restraints
Figure 3: Latin America Cell Analysis Market, 2017-2025
Figure 4: Latin America Cell Analysis Market (by Product Type), 2017 and 2025
Figure 5: Latin America Instruments Cell Analysis Market (by Type), 2017-2025
Figure 6: Latin America Cell Analysis Market (by End User), 2017-2025
Figure 7: Latin America Cell Analysis Market (by Country), 2017-2025
Figure 8: Insights Pertaining to the Cell Analysis Market Across Different Countries of Latin America
Figure 1.1: Global Cell Analysis Market Segmentation
Figure 1.2: Drug Development Process
Figure 1.3: Latin America Cell Analysis Market, 2017-2025
Figure 2.1: Market Dynamics of LATAM Cell Analysis Market
Figure 3.1: Market Share Analysis: Latin America Cell Analysis Market, 2016 and 2017
Figure 3.2: Porter?s Five Forces Analysis
Figure 3.3: Bargaining Power of Suppliers: Overall Impact, 2014-2025
Figure 3.4: Bargaining Power of Buyers: Overall Impact, 2014-2025
Figure 3.5: Threat of New Entrant: Overall Impact, 2014-2025
Figure 3.6: Threat of Substitute Products: Overall Impact, 2014-2025
Figure 3.7: Intensity of Competitive Rivalry: Overall Impact, 2014-2025
Figure 4.1: Some of The Strategies of Cell Therapy
Figure 4.2: Types of Cell Therapy
Figure 4.3: Types of Stem Cells
Figure 4.4: Latin America Cell Analysis Market (by Product Type)
Figure 4.5: Latin America Cell Analysis Market (by Product Type), 2017-2025
Figure 4.6: Latin America Cell Analysis Market (by Instruments), 2017-2025
Figure 4.7: Latin America Instruments Cell Analysis Market (by Cell Imaging Systems and Microscopes), 2017-2025
Figure 4.8: Latin America Instruments Cell Analysis Market (by Flow cytometer), 2017-2025
Figure 4.9: Latin America Instruments Cell Analysis Market (by Quantitative PCR Instruments), 2017-2025
Figure 4.10: Latin America Instruments Cell Analysis Market (by Cell Counters), 2017-2025
Figure 4.11: Latin America Instruments Cell Analysis Market (by Cell Screening and High-Content Screening Systems (HCS)), 2017-2025
Figure 4.12: Latin America Instruments Cell Analysis Market (by Other Instruments), 2017-2025
Figure 4.13: Latin America Cell Analysis Market (by Consumables), 2017-2025
Figure 4.14: Latin America Consumables Cell Analysis Market (by Type), 2017-2025
Figure 4.15: Latin America Consumables Cell Analysis Market (by Assay Kits), 2017-2025
Figure 4.16: Latin America Consumables Cell Analysis Market (by Reagents), 2017-2025
Figure 4.17: Latin America Consumables Cell Analysis Market (by Other Consumables), 2017-2025
Figure 5.1: Latin America Cell Analysis Market (by End User)
Figure 5.2: Latin America Cell Analysis Market (by End User), 2017-2025
Figure 5.3: Latin America Cell Analysis Market (by Hospitals), 2017-2025
Figure 5.4: Latin America Cell Analysis Market (by Pharmaceutical and Biotechnology Companies), 2017-2025
Figure 5.5: Latin America Cell Analysis Market (by Contract Research Organizations (CROs) and Contract Manufacturing Organization (CMOs), 2017-2025
Figure 5.6: Latin America Cell Analysis Market (by Academic and Research Institutes), 2017-2025
Figure 5.7: Latin America Cell Analysis Market (by Others), 2017-2025
Figure 6.1: Latin America Cell Analysis Market, 2017-2025
Figure 6.2: Latin America Cell Analysis Market (by Country), 2017-2025
Figure 6.3: Brazil Cell Analysis Market, 2017-2025
Figure 6.4: Mexico Cell Analysis Market, 2017-2025
Figure 6.5: Argentina Cell Analysis Market, 2017-2025
Figure 6.6: Chile Cell Analysis Market, 2017-2025
Figure 6.7: Colombia Cell Analysis Market, 2017-2025
Figure 6.8: Rest-of-Latin America Cell Analysis Market, 2017-2025
Figure 7.1: Shares of Key Company Profiles
Figure 7.2: Becton, Dickinson and Company: Product Offerings
Figure 7.3: Becton, Dickinson and Company: Overall Financials, 2015-2017
Figure 7.4: Becton, Dickinson and Company: Revenue (by Segment), 2015-2017
Figure 7.5: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2015-2017
Figure 7.6: Becton, Dickinson and Company: Revenue (by Region), 2015-2017
Figure 7.7: Becton, Dickinson and Company: R&D Expenditure, 2015-2017
Figure 7.8: Becton, Dickinson and Company: SWOT Analysis
Figure 7.9: Bio-Rad Laboratories, Inc.: Product Offerings
Figure 7.10: Bio-Rad laboratories, Inc.: Overall Financials, 2015-2017
Figure 7.11: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.12: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2015-2017
Figure 7.13: Bio-Rad Laboratories, Inc.: R&D Expense, 2015-2017
Figure 7.14: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 7.15: Danaher Corporation: Product Offerings
Figure 7.16: Danaher Corporation: Overall Financials, 2015-2017
Figure 7.17: Danaher Corporation: Revenue (by Segment), 2015-2017
Figure 7.18: Danaher Corporation: Revenue (by Region), 2015-2017
Figure 7.19: Danaher Corporation: R&D Expenditure, 2015-2017
Figure 7.20: Danaher Corporation: SWOT Analysis
Figure 7.21: F. Hoffmann-La Roche AG: Product Offerings
Figure 7.22: F. Hoffmann-La Roche AG: Overall Financials, 2015-2017
Figure 7.23: F. Hoffmann-La Roche AG: Revenue (by Segment), 2015-2017
Figure 7.24: F. Hoffmann-La Roche AG: Revenue (by Region), 2015-2017
Figure 7.25: F. Hoffmann-La Roche AG: R&D Expenditure, 2015-2017
Figure 7.26: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 7.27: GE Corporation: Product Offerings
Figure 7.28: GE Corporation Limited: Overall Financials, 2015-2017
Figure 7.29: GE Corporation: Revenue (by Business Segment), 2015-2017
Figure 7.30: GE Corporation: Revenue (by Region), 2015-2017
Figure 7.31: GE Corporation R&D Expenditure, 2014-2017
Figure 7.32: GE Corporation: SWOT Analysis
Figure 7.33: Merck KGaA: Product Offerings
Figure 7.34: Merck & Co., Inc.: Overall Financials, 2015-2017
Figure 7.35: Merck & Co., Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.36: Merck & Co., Inc.: Revenue (by Region), 2015-2017
Figure 7.37: Merck & Co., Inc. R&D Expenditure, 2015-2017
Figure 7.38: Merck & Co., Inc.: SWOT Analysis
Figure 7.39: Olympus Corporation: Overall Financials, 2015-2017
Figure 7.40: Olympus Corporation: Revenue (by Business Segment), 2015-2017
Figure 7.41: Olympus Corporation: Revenue (by Region), 2015-2017
Figure 7.42: Olympus Corporation R&D Expenditure, 2015-2017
Figure 7.43: Olympus Corporation: SWOT Analysis
Figure 7.44: PerkinElmer, Inc.: Product Offerings
Figure 7.45: PerkinElmer, Inc.: Overall Financials, 2015-2017
Figure 7.46: PerkinElmer, Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.47: PerkinElmer, Inc.: Revenue (by Region), 2015-2017
Figure 7.48: PerkinElmer, Inc. R&D Expenditure, 2015-2017
Figure 7.49: PerkinElmer, Inc.: SWOT Analysis
Figure 7.50: Qiagen N.V.: Overall Financials, 2015-2017
Figure 7.51: Qiagen N.V.: Revenue (by Business Segment), 2015-2017
Figure 7.52: Qiagen N.V.: Revenue (by Region), 2015-2017
Figure 7.53: Qiagen N.V.: R&D Expense, 2015-2017
Figure 7.54: Qiagen N.V.: SWOT Analysis
Figure 7.55: Sony Biotechnology Inc.: Product Offerings
Figure 7.56: Thermo Fisher Scientific Inc.: Product Offerings
Figure 7.57: Thermo Fisher Scientific Inc.: Overall Financials, 2015-2017
Figure 5.58: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.59: Thermo Fisher Scientific Inc.: Revenue (by Region), 2015-2017
Figure 7.60: Thermo Fisher Scientific Inc.: R&D Expense, 2015-2017
Figure 7.61: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 8.1: Latin America Cell analysis: Market Segmentation
Figure 8.2: Reserach Methodology
Figure 8.3: Primary Research
Figure 8.4: Secondary Research
Figure 8.5: Data Triangulation
Figure 8.6: Top-down Approach (Segment-wise Analysis)
Figure 8.7: Bottom-up Approach (Segment-wise Analysis)
Figure 8.8: Assumptions and Limitations
Figure 8.9: Considered Factors for Data Prediction and Modelling